The only technical publication devoted exclusively to readers involved in development and production of orally inhaled and nasal drug products (OINDPs).


Point of view: A proposed roadmap for sustainable inhaler use in the UK that could support the NHS net zero ambition

Limitations of metrics used in the regulation of aerodynamic particle size distributions (APSDs) of orally inhaled products (OIPs)

Cascade impactor stage groupings: Poor decisions from degraded data

Back Pages:

Inspiring asthma management in young people
Food allergy awareness on college campuses

Cross-Industry Organizations:

A review of RDD® Europe 2023 and look ahead to RDD 2024

Show Preview:

Previewing DDL2023

In vitro methods for estimation of total and regional lung deposition of orally inhaled products

An overview of The European Pharmaceutical Aerosol Group (EPAG)


Industry Organizations

Inhalation 1-2-3

Reference & Buyer’s Resource

Editorial Advisory Board




White Papers